Schroder Investment Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $742M | Sell |
12,235,494
-318,868
| -3% | -$18.6M | 0.61% | 26 |
|
|
2025
Q4 | $681M | Buy |
12,554,362
+385,371
| +3% | +$18.5M | 0.52% | 35 |
|
|
2025
Q3 | $549M | Sell |
12,168,991
-1,525,068
| -11% | -$71.2M | 0.43% | 50 |
|
|
2025
Q2 | $634M | Buy |
13,694,059
+3,583,855
| +35% | +$176M | 0.54% | 35 |
|
|
2025
Q1 | $617M | Sell |
10,110,204
-1,303,224
| -11% | -$76M | 0.62% | 32 |
|
|
2024
Q4 | $640M | Buy |
11,413,428
+3,787,075
| +50% | +$212M | 0.61% | 31 |
|
|
2024
Q3 | $395M | Buy |
7,626,353
+952,801
| +14% | +$44.7M | 0.4% | 49 |
|
|
2024
Q2 | $277M | Buy |
6,673,552
+2,101,253
| +46% | +$94M | 0.31% | 68 |
|
|
2024
Q1 | $248M | Buy |
4,572,299
+1,106,383
| +32% | +$56.4M | 0.29% | 70 |
|
|
2023
Q4 | $178M | Buy |
3,465,916
+697,388
| +25% | +$36.6M | 0.23% | 87 |
|
|
2023
Q3 | $161M | Sell |
2,768,528
-716,893
| -21% | -$43.9M | 0.24% | 82 |
|
|
2023
Q2 | $223M | Sell |
3,485,421
-4,439,679
| -56% | -$298M | 0.32% | 64 |
|
|
2023
Q1 | $549M | Sell |
7,925,100
-1,307,974
| -14% | -$92.3M | 0.82% | 22 |
|
|
2022
Q4 | $664M | Sell |
9,233,074
-379,134
| -4% | -$28.6M | 1.05% | 15 |
|
|
2022
Q3 | $683M | Sell |
9,612,208
-337,833
| -3% | -$24.5M | 1.13% | 12 |
|
|
2022
Q2 | $766M | Buy |
9,950,041
+1,123,694
| +13% | +$85.6M | 1.17% | 11 |
|
|
2022
Q1 | $646M | Buy |
8,826,347
+814,621
| +10% | +$54.7M | 0.85% | 17 |
|
|
2021
Q4 | $500M | Buy |
8,011,726
+897,369
| +13% | +$52.6M | 0.65% | 29 |
|
|
2021
Q3 | $421M | Buy |
7,114,357
+370,513
| +5% | +$24.4M | 0.65% | 24 |
|
|
2021
Q2 | $451M | Buy |
6,743,844
+1,470,987
| +28% | +$95.9M | 0.56% | 30 |
|
|
2021
Q1 | $333M | Buy |
5,272,857
+747,373
| +17% | +$46.5M | 0.43% | 45 |
|
|
2020
Q4 | $281M | Sell |
4,525,484
-80,389
| -2% | -$4.94M | 0.4% | 44 |
|
|
2020
Q3 | $270M | Buy |
4,605,873
+62,953
| +1% | +$3.79M | 0.43% | 45 |
|
|
2020
Q2 | $267M | Buy |
4,542,920
+60,679
| +1% | +$3.63M | 0.48% | 40 |
|
|
2020
Q1 | $259M | Buy |
4,482,241
+217,750
| +5% | +$13.3M | 0.55% | 34 |
|
|
2019
Q4 | $274M | Buy |
4,264,491
+683,684
| +19% | +$39.2M | 0.45% | 46 |
|
|
2019
Q3 | $180M | Sell |
3,580,807
-1,109,325
| -24% | -$52.1M | 0.32% | 68 |
|
|
2019
Q2 | $213M | Buy |
4,690,132
+270,185
| +6% | +$12.6M | 0.39% | 57 |
|
|
2019
Q1 | $211M | Buy |
4,419,947
+387,057
| +10% | +$19.3M | 0.38% | 59 |
|
|
2018
Q4 | $210K | Buy |
4,032,890
+615,786
| +18% | +$33.1M | 0.38% | 50 |
|
|
2018
Q3 | $212M | Sell |
3,417,104
-434,644
| -11% | -$25.8M | 0.36% | 63 |
|
|
2018
Q2 | $213M | Buy |
3,851,748
+3,109,664
| +419% | +$168M | 0.37% | 60 |
|
|
2018
Q1 | $46.9M | Buy |
742,084
+87,983
| +13% | +$5.66M | 0.08% | 290 |
|
|
2017
Q4 | $40.1M | Buy |
654,101
+95,204
| +17% | +$5.95M | 0.07% | 339 |
|
|
2017
Q3 | $35.2M | Buy |
558,897
+142,997
| +34% | +$8.35M | 0.06% | 353 |
|
|
2017
Q2 | $23.2M | Buy |
415,900
+198,629
| +91% | +$10.8M | 0.04% | 441 |
|
|
2017
Q1 | $12M | Buy |
217,271
+47,997
| +28% | +$2.63M | 0.02% | 580 |
|
|
2016
Q4 | $9.89M | Sell |
169,274
-159,785
| -49% | -$8.74M | 0.02% | 618 |
|
|
2016
Q3 | $17.7M | Sell |
329,059
-1,531,486
| -82% | -$98.4M | 0.03% | 512 |
|
|
2016
Q2 | $137M | Sell |
1,860,545
-99,391
| -5% | -$7.02M | 0.27% | 85 |
|
|
2016
Q1 | $124M | Buy |
1,959,936
+1,521,947
| +347% | +$96M | 0.26% | 93 |
|
|
2015
Q4 | $30.1M | Sell |
437,989
-30,607
| -7% | -$2.02M | 0.06% | 365 |
|
|
2015
Q3 | $27.7M | Sell |
468,596
-18,513
| -4% | -$1.17M | 0.06% | 375 |
|
|
2015
Q2 | $32.1M | Sell |
487,109
-86,022
| -15% | -$5.67M | 0.06% | 360 |
|
|
2015
Q1 | $37.4M | Sell |
573,131
-499,819
| -47% | -$31.3M | 0.07% | 325 |
|
|
2014
Q4 | $63.3M | Sell |
1,072,950
-94,267
| -8% | -$5.32M | 0.12% | 209 |
|
|
2014
Q3 | $59.7M | Buy |
1,167,217
+370,514
| +47% | +$18.5M | 0.08% | 233 |
|
|
2014
Q2 | $38.6M | Sell |
796,703
-2,086,760
| -72% | -$103M | 0.05% | 332 |
|
|
2014
Q1 | $150M | Sell |
2,883,463
-187,491
| -6% | -$9.98M | 0.17% | 115 |
|
|
2013
Q4 | $163M | Sell |
3,070,954
-844,236
| -22% | -$43M | 0.2% | 93 |
|
|
2013
Q3 | $181M | Sell |
3,915,190
-904,616
| -19% | -$39.7M | 0.44% | 50 |
|
|
2013
Q2 | $215M | Buy |
+4,819,806
| New | +$209M | 0.57% | 33 |
|
Other funds holding BMY
VCM
VPM
Schroder Investment Management Group's BMY Position: Q1 2026 in Review
Schroder Investment Management Group reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2026, selling an estimated $18.6M and leaving 12,235,494 shares worth $742M. The position accounts for 0.61% of the portfolio, ranked #26.
Schroder Investment Management Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $766M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Schroder Investment Management Group held 12,235,494 shares of Bristol-Myers Squibb worth $742M as of Q1 2026.
- Schroder Investment Management Group sold 318,868 Bristol-Myers Squibb shares in Q1 2026, an estimated $18.6M.
- Bristol-Myers Squibb made up 0.61% of Schroder Investment Management Group's portfolio in Q1 2026, its #26 holding.
- Schroder Investment Management Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Schroder Investment Management Group's Bristol-Myers Squibb position peaked at $766M in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Schroder Investment Management Group's 13F filing for Q1 2026, filed 14 May 2026.